Golden Kids Dental Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 2421 Ford St., Golden, CO 80401 Phone: 303-216-1108 Fax: 303-216-1248 |
Rocky Mountain Dental Anesthesia Dentist - Dentist Anesthesiologist Medicare: Not Enrolled in Medicare Practice Location: 811 Brickyard Cir, Golden, CO 80403 Phone: 559-367-2336 |
John M. Burchfield, Dds, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2007 Jackson St, Golden, CO 80401 Phone: 303-279-3992 |
Clear Creek Dental Clinic Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1600 Washington Ave, Golden, CO 80401 Phone: 303-279-6621 Fax: 303-216-0278 |
Becoming Me Cavity Free Dental Cottage Dentist Medicare: Not Enrolled in Medicare Practice Location: 623 14th St, Golden, CO 80401 Phone: 303-279-5900 |
Perfect Teeth - Golden P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 17211 S Golden Rd, #100, Golden, CO 80401 Phone: 303-279-7444 Fax: 303-279-8011 |
Genesee Dental Group Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 25918 Genesee Trail Rd Suite 210, Golden, CO 80401 Phone: 303-526-9155 Fax: 303-526-9277 |
News Archive
Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
The first study of uterine fibroid embolization to treat post-menopausal women shows that the non-surgical treatment was technically successful in 100 percent of patients, and improved bulk-related symptoms in 92 percent of the women.
When Jude Grosser's daughter, Melinda, was in elementary school, he would often take her to his laboratory at the University of Florida's Citrus Research and Education Center, where he works as a researcher on citrus diseases and creating new varieties.
› Verified 3 days ago